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Type I IFN inductionAlphaviruses are mosquito-borne viruses that cause serious human and animal diseases. Previous studies
demonstrated that a determinant within the nsP1/nsP2 cleavage domain of the virulent Sindbis AR86 virus
played a key role in regulating adult mouse virulence without adversely affecting viral replication. Additional
characterization of this determinant demonstrated that a virus with the attenuating mutation induced more
type I IFN production both in vivo and in vitro. Interestingly, this phenotype was not speciﬁc to the Sindbis
AR86 virus, as a similar mutation in a distantly related alphavirus, Ross River Virus (RRV), also led to
enhanced IFN induction. This effect was independent of virus-induced host shutoff, since IRF-3
phosphorylation, which occurs independently of de novo host transcription/translation, was induced more
robustly in cells infected with the mutant viruses. Altogether, these results demonstrate that critical
determinants within the nsP1/nsP2 cleavage domain play an important role in regulating alphavirus-
induced IFN responses.e University of North Carolina,
l Hill, NC 27599, USA. Fax: +1
ll rights reserved.© 2009 Elsevier Inc. All rights reserved.Introduction
Alphaviruses are mosquito-borne viruses capable of infecting
humans and causing various diseases ranging from acute encephalitis
to long-term virus-induced arthritis. The Sindbis-group viruses are
among the most studied and well characterized of the alphaviruses,
having been used to identify viral and host factors that contribute to
virus-induced disease in mice (Morrison et al., 2008; Ryman et al.,
2002; Suthar et al., 2005). The majority of the Sindbis virus strains are
avirulent in adultmice, however, there are a few exceptions, including
the neurovirulent neuroadapted Sindbis virus (NSV) (Tucker et al.,
1993) and AR86 strains (Heise et al., 2000; Simpson et al., 1996).
Genetic studies have mapped virulence determinants of these
neurovirulent viruses to both the structural and nonstructural
proteins. Detailed genetic mapping studies using chimeric viruses
that encode regions of the adult mouse virulent AR86 and the closely
related avirulent GirdwoodS.A identiﬁed four major neurovirulence
determinants in the AR86 genome including, a Threonine at nsP1position 538, an 18-amino acid deletion at nsP3 386, a Cysteine at
nsP3 position 537, and a Serine at E2 position 243 (Suthar et al., 2005).
While all four determinants were found to be essential for adult
mouse virulence, the determinantwithin nsP1was found to be critical;
as a single coding change of this determinant from a Thr to Ile severely
attenuated the virus, while introduction of a Thr at this position into
non-virulent viruses partially rescued virulence (Heise et al., 2000).
Currently, the exactmechanismbywhich this determinant affects viral
virulence is not understood.
The alphavirus nonstructural proteins form the viral replication
complex that mediates cytoplasmic viral RNA synthesis within infected
cells. Nonstructural polyprotein processing is intimately linked to viral
RNA synthesis (Lemm and Rice, 1993; Shirako and Strauss, 1994). Upon
viral entry, the virion-associated RNA is immediately translated to form
the replication complex consisting of the nonstructural precursor, nsP123,
and nsP4,which togethermediate negative strandRNA synthesis (Strauss
and Strauss, 1994). Later in the course of infection, the polyprotein
precursor nsP123 is further processed by nsP2 to produce mature nsP1,
nsP2, and nsP3. The mature nonstructural proteins, together with nsP4,
form the replication complex to synthesize full length genomic RNA. The
mature nsPs also bind to an internal subgenomic promoter to synthesize
smaller subgenomic RNAs that encode the viral structural proteins.
Previous studies using mutants that lack the ability to efﬁciently process
the nonstructural polyprotein precursor nsP123 showed dysregulation of
Fig. 1. The mutant SIN T538I virus induces more type I interferon. (A) Groups of six-
week old (n=3) CD-1 mice were infected with diluent alone, wild type Sindbis AR86,
or Sindbis T538I mutant at 1×103 PFU via the intracranial (i.c.) route. Serum was
harvested at the indicated time points (hours) and diluted (1:10) into media. (B) L929
cells were either mock infected or infected with wild type AR86 or T538I mutant at an
MOI of 5.0 and supernatants were harvested at 18 h post-infection. Serum and
supernatants were subjected to an interferon bioassay on L929 cells. Each bar
represents the average of triplicate samples and the p values were determined by
ANOVA statistical analysis. Error bars represent the standard error of the mean. The
limit of detection in each bioassay was 31 IU/ml.
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AR86 Thr to Ile change at nsP1position 538, is located in the P3 position of
the conserved nsP1/2 cleavage recognition domain (Shirako and Strauss,
1994). The presence of an attenuating Ile at this position results in
increased kinetics of nonstructural polyprotein processing as well as
earlier induction of 26S subgenomic RNA synthesis. Furthermore, this
mutation did not affect full length negative or positive strand RNA
synthesis, though it did result in increased virus production (Heise et al.,
2003). Whether differential nonstructural protein processing or the
increased 26S RNA is important for the attenuated phenotype of this virus
in vivo has yet to be determined.
In addition to mediating viral replication, the nonstructural
proteins interact with host factors to alter environmental conditions
that favor viral replication (Garmashova et al., 2006; Montgomery et
al., 2006). The nonstructural proteins of Old World alphaviruses, such
as Sindbis and Semliki Forest virus, have been shown to mediate
shutoff of host transcription and translation (Garmashova et al.,
2007). While the exact mechanism of virus-mediated host shutoff is
not completely understood, it has been proposed that mature nsP2 is
required (Gorchakov et al., 2005; Gorchakov et al., 2008). Alpha-
viruses are thought to down regulate host mRNA and protein
synthesis in order to limit competition for the cellular machinery to
maximize viral replication while simultaneously limiting induction of
type I IFN and related IFN stimulated genes (ISGs).
Sindbis viruses are highly sensitive to the effects of type I IFN
(Frolova et al., 2002). Type I IFN receptor deﬁcient mice exhibited
enhanced susceptibility to Sindbis virus marked by increased
virulence, broadened tissue tropism, and uncontrolled virus replica-
tion (Ryman et al., 2000), demonstrating that type I IFN plays an
important role in controlling Sindbis virus infection. Therefore, it is
likely that Sindbis virus utilizes several mechanisms to limit and/or
suppress type I IFN induction. One likely mechanism involves
generalized suppression of host macromolecular synthesis. In support
of this, Sindbis virus mutants that are defective for host shutoff are
more potent inducers of the type I IFN response (Gorchakov et al.,
2005; Gorchakov et al., 2008). However, host shutoff independent
mechanisms likely exist, as a mutation in the nsP2 protein of Semliki
Forest Virus, a related alphavirus, affects type I IFN induction
independently of generalized host shutoff (Breakwell et al., 2007).
In this study, we demonstrate an important role for a determinant
at the P3 cleavage position between nsP1 and nsP2 in regulating type I
IFN induction. Mutation of this position in two distantly related
alphaviruses, the AR86 strain of Sindbis and Ross River Virus, resulted
in enhanced type I IFN induction and IRF-3 activation in comparison to
the wild type viruses. Furthermore, the P3 mutation had little effect
on kinetics of virus-mediated host transcription and translation
shutoff. Taken together, these results suggest that the P3 determinant,
which regulates AR86 virulence, plays a major role in regulating type I
IFN induction that is independent of virus-mediated host shutoff.
Results
An attenuating Isoleucine mutation at nsP1 position 538 (T538I) in the
Sindbis virus AR86 backbone leads to increased type I IFN induction in
vivo and in vitro
A virulence determinant located within the nsP1/nsP2 cleavage
domain (nsP1 538) of the Sindbis virus, AR86, regulates viral
nonstructural polyprotein processing and subgenomic RNA synthesis
(Heise et al., 2003). Given that the presence of the attenuating Ile
mutation led to earlier induction of viral 26S RNA synthesis, which
could alter type I IFN induction, we assessed whether the attenuated
mutant virus exhibited any differences in type I IFN induction from
that of the wild type virus both in vivo and in vitro. To evaluate
whether the viruses exhibited differential IFN induction in vivo, six-
week old CD-1miceweremock infected or infectedwith thewild typeAR86 (previously referenced as s300 (Suthar et al., 2005)) or mutant
T538I (nsP1 538 Ile previously referenced as s340) viruses by the
intracranial route (i.c.) and bled between 9 and 18 h post-infection.
Serum type I interferon responses were measured using an interferon
bioassay on L929 cells. As shown in Fig. 1A, serum from mice infected
with the mutant T538I virus exhibited robust type I interferon levels
compared to mice infected with the wild type AR86 virus at both 12
and 18 h post-infection as detectable by bioassay. Similar results were
observed in C57BL/6 mice (data not shown). Importantly, wild type
AR86 did not induce detectable type I interferon up to 48 h post-
infection (data not shown), indicating that the wild type virus was not
simply delayed in the induction of type I interferon. To further assess
whether the mutant virus was a more potent inducer of type I IFN,
L929 cells were infected with either the wild type AR86 virus or the
T538I mutant and type I IFN levels in the supernatant were evaluated.
As shown in Fig. 1B, similar to the in vivo results, the attenuated
mutant was a more potent inducer of type I IFN than the wild type
virus. These results were not restricted to L929 cells, since the mutant
virus was also a more potent IFN inducer in human cell lines such as
A549 cells (data not shown). Overall, these results suggest that the
determinant at nsP1 position 538 plays a major role in regulating type
I IFN induction by the virus.
Previous studies with Sindbis viruses have suggested that virus-
mediated host cellular macromolecular shutoff is linked to IFN
induction. Some Sindbis virus mutants that are potent IFN inducers
are also defective in their ability to shutoff host RNA synthesis
(Gorchakov et al., 2005), raising the possibility that the nsP1mutation
in AR86 affected type I IFN induction through effects on host
macromolecular synthesis. Therefore, we assessed the kinetics of
3C.C. Cruz et al. / Virology 399 (2010) 1–10transcriptional and translational shutoff between the wild type and
mutant AR86 viruses. These studies utilized L929 cells, since the T538I
mutant exhibited enhanced type I IFN induction in this cell type
(Fig. 1B). Unfortunately, we were unable to achieve 100% infection at
low MOIs. Therefore, the MOI was increased to 50 to increase the
percent of infected cells and to limit the confounding effect of
nonproductively infected cells in the culture continuing transcrip-
tion/translation and complicating the analysis of virus-induced
shutoff of these processes. As shown in Fig. 2A, both the wild type
and the mutant viruses exhibited similar kinetics of host transcription
shutoff at 5 h post-infection as observed by the loss of host mRNA, 28S
rRNA, and 18S rRNA. By 8 hpi, both viruses have efﬁciently turned off
host transcription. Interestingly, in Neuro2A cells, the wild type
Sindbis AR86 virus exhibited less efﬁcient shutoff of host mRNA, 28SFig. 2. The Sindbis T538I mutant virus shuts off host RNA transcription and protein translat
infected with wild type Sindbis AR86 (T) or mutant T538I (I) at an MOI of 50. (A) To analyz
replaced with media containing 20 μCi/ml of 3H-Uridine and cells were labeled for a total of 3
Materials andMethods. (B) To analyze host protein synthesis, L929 cells were labeledwith 35
SDS-PAGE. (C) Residual host cell protein synthesis in B was evaluated by measuring the amo
the arrow) and normalized to the amount of radioactivity detected in the same protein band
independent experiments.rRNA and 18S rRNA as compared to themutant T538I virus suggesting
that the T538I mutant may actually shutoff transcription more
efﬁciently than the wild type virus (data not shown). Additionally,
the wild type and mutant Sindbis viruses were equally efﬁcient at
inhibiting host protein translation (Figs. 2B and C). As early as 4 h
post-infection, both viruses exhibit greater than 25% shutoff of host
protein synthesis and by 8 h post-infection greater than 75% of host
protein synthesis shutoff was observed (Fig. 2C). Most importantly,
when comparing the β-actin band, the mutant T538I virus displayed
similar kinetics of host protein shutoff as compared to wild type AR86
virus (Fig. 2B). Similar observations were also made in Neuro2A and
BHK-21 cells (data not shown). These results suggest that the Sindbis
virus mutant induced enhanced type I IFN production in the absence
of a detectable defect in generalized host cell shutoff.ion with similar kinetics to the wild type AR86. L929 cells were mock infected (M) or
e host RNA synthesis, at various times post-infection (2, 5, 8, and 16 h), the media was
h. Total RNAwas harvested and analyzed by agarose gel electrophoresis as described in
SMet/Cys for 1 h at the hours indicated and cell lysates (in duplicates) were analyzed by
unt of radioactivity detected in the protein band corresponding to actin (as marked by
in mock infected cells (AR86—□; T538I—▴). The data shown are representative of two
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type I IFN production
To determine if the effect of the amino acid within the nsP1/nsP2
cleavage domain on type I IFN induction was speciﬁc to AR86,
similar mutations were introduced in the distantly related alpha-
virus, Ross River Virus (RRV) (Fig. 3A). RRV encodes an Alanine
codon at the same position within the nsP1/2 cleavage site and we
examined whether substitution with an Isoleucine (A532I) or Valine
(A532V) would result in a viable virus with similar effects on type I
IFN induction as seen with the Sindbis T538I mutant (Fig. 1).
Substitution of an Isoleucine in RRV resulted in a signiﬁcantly
attenuated virus that grew poorly in BHK-21 cells (data not shown).
In contrast, substitution of an Alanine to Valine resulted in a viable
virus that grew to levels comparable to wild type RRV, though the
Valine mutant displayed a smaller plaque phenotype on BHK-21
cells (data not shown). Furthermore, the RRV A532V mutant had a
similar RNA speciﬁc infectivity and particle to PFU ratio to those
observed with the wild type virus (data not shown). In both single
(Fig. 3B) and multi-step (Fig. 3C) growth curves in BHK-21 cells, the
A532V mutant exhibited a signiﬁcant and reproducible reduction in
viral yield at intermediate times (7–16 hpi), although the endpoint
yield was identical to wild type RRV. Therefore, the A532V mutant is
viable, though it may exhibit a slight replication defect as compared
to the wild type virus.
In order to assess the impact of the A532V mutation on type I IFN
induction, L929 cells were infected with either the wild type RRV or
the RRV A532V mutant, and type I IFN induction in the supernatant
was measured by bioassay. As shown in Fig. 4A, the A532V mutant
exhibited enhanced IFN induction (∼90 fold) in comparison to wild
type RRV at 24 h post-infection. Similar results were found by qRT-Fig. 3. Characterizations of the RRV A532V mutant virus. (A) Schematic diagram of the singl
A532V) mutants. (B) Single step growth curve. BHK cells were infected at an MOI of 5 with
analyzed by plaque assay. (C) Multi-step growth curve. BHK-21 cells were infected at an MO
25 hpi were analyzed by plaque assays. Each data point represents the average of triplica
(⁎pb0.05, ⁎⁎pb0.01). Error bars represent the standard error of the mean.PCR analysis for IFN-beta mRNA transcripts at early times post-
infection (Figs. 4B and C). Altogether, these data, along with the
earlier ﬁndings with the Sindbis AR86 viruses, highlight the
importance of the determinant within the nsP1/nsP2 cleavage site
in modulating type I IFN responses by at least two alphaviruses.
The A532V mutation affects type I IFN induction
Recent work from our group and others has demonstrated that
another alphavirus, Venezuelan equine encephalitis virus (VEEV) can
antagonize STAT1 activation following treatment with type I IFN
(Simmons et al., 2009; Yin et al., 2009). Although, to date we have
found no evidence that wild type RRV can antagonize STAT1
activation (Simmons and Heise, unpublished), we were interested
in determining whether the A532V mutation affected the early
induction of type I IFN or the ampliﬁcation phase of the type I IFN
response, which is dependent upon type I IFN signaling and STAT1
activation. Thus, we compared the wild type and mutant A532V RRV
viruses for their ability to induce type I IFN in primary MEFs derived
from wild type mice or mice deﬁcient in the type I IFN αβ receptor
(IFNR), which are therefore unable to mount an ampliﬁed type I IFN
response. As shown in Fig. 5A, similar to the results from the L929
cells, the mutant virus was a more potent type I IFN inducer than wild
type RRV in wild type MEFs. In IFNR deﬁcient MEFs, the overall type I
IFN induction was reduced compared to wild type cells, however the
mutant virus still induced signiﬁcantly more type I IFN than the wild
type virus (Fig. 5B). Therefore, though we cannot rule out an effect of
the A532V mutation on type I IFN signaling and subsequent
ampliﬁcation of the IFN response, these results strongly suggest that
the nsP1 mutation does have an effect on the inductive phase of the
type I IFN response.e amino acid substitutions in the Sindbis AR86 (T538I) and Ross River Virus (A532I and
either RRV (▪) or A532V (Δ) viruses. Supernatants at 1, 4, 7, 10, 13, and 25 hpi were
I of 0.01 with either RRV (▪) or A532V (Δ) viruses. Supernatants at 4, 7, 10, 13, 16, and
te samples and signiﬁcance was determined by a 2-factor ANOVA statistical analysis
Fig. 4. The RRV A532V mutant virus induces more type I IFN than the wild type. L929
cells were infected with RRV and A532V viruses at an MOI of 5. (A) Type I IFN bioassays
were performed on the supernatants harvested at 24 hpi. The limit of detection for the
bioassay is 7 IU/ml. (B and C) Total RNA was extracted at 6 hpi (B) or 12 hpi (C) and
analyzed by quantitative real-time PCR (Applied Biosystems) for IFN-beta message
transcripts. The data are represented as the fold induction over Mock infected cells and
have been normalized to 18S rRNA. Each bar above represents the average of triplicate
samples and the p values were determined by ANOVA statistical analysis. Error bars
represent the standard error of the mean.
Fig. 5. The RRV mutant virus induces more IFN than the wild type RRV in the absence of
the type I IFN αβ receptor. (A) Sv/129 MEFS and (B) Sv/129 IFNR−/− MEFS were
infected with RRV and A532V viruses at an MOI of 5. Type I IFN bioassays were
performed on the supernatants harvested at 24 hpi. Each bar represents the average of
triplicate samples and the p values were determined by ANOVA statistical analysis.
Error bars represent the standard error of the mean and the limit of detection for each
bioassay is 61 IU/ml).
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RNA and protein synthesis
The Sindbis T538I mutant exhibited little defect in virus-induced
shutoff, therefore we determined whether this was also the case with
the RRV A532Vmutant. RRV or A532V were evaluated for their ability
to shut off host protein and RNA synthesis in a manner similar to that
described above for AR86. L929 cells were infected with the RRV
viruses at an MOI of 50 to enhance the percentage of infected cells in
the culture. At this MOI, the percentage of infected cells was greater
than 80% for both viruses as demonstrated by an Immunoﬂuorescent
Assay (IFA) (data not shown). Importantly, the RRV A532V mutant
still induced an enhanced IFN response compared to the wild type
virus at this MOI (Fig. 6D). Both wild type RRV and the mutant A532V
viruses inhibited cellular RNA transcription as early as 5 h post-
infection as indicated by the decline in 18S rRNAs as compared to
mock infected cells (Fig. 6A). By 8 h post-infection, both viruses
efﬁciently turned off 18S rRNA synthesis. Similar results were also
obtained in BHK cells though interestingly, in BHK cells, the A532Vmutant displayed a slight delay in transcriptional shutoff at early
times post-infection compared to the wild type RRV virus (data not
shown). Therefore, though the A532V mutant is capable of shutting
off host RNA synthesis we cannot rule out the possibility that the
A532V mutant virus may be slightly delayed in its ability to turn off
cellular RNA synthesis. Analysis of virus-induced inhibition of host
protein synthesis (Fig. 6B) demonstrated that both viruses inhibit
cellular protein synthesis in L929 cells with similar kinetics as
indicated by the loss of the β-actin band (Fig. 6C). Similarly to the
transcriptional shutoff data, in BHK cells, the A532V mutant was
slightly delayed in inhibiting protein translation in comparison to the
wild type virus (data not shown). Therefore, though the mutant RRV
is ultimately able to shut off host cell RNA and protein synthesis, based
on these results, we cannot rule out the possibility that a slight defect
in shutoff might contribute to the enhanced type I IFN induction by
the A532V RRV mutant.
The A532V mutant virus is a strong inducer of IRF-3 phosphorylation
than the wild type virus
The results with the Sindbis T538I mutant suggest that host shutoff
defects do not contribute to the enhanced type I IFN induction by the
mutant virus. Furthermore, though we could not detect a defect in the
RRV A532Vmutant's ability to shutoff host transcription or translation
in L929 cells, the delayed kinetics of shutoff by the A532V mutant in
BHK cells left open the possibility of shutoff dependent effects for the
RRVmutant. Therefore, to more clearly address this issue, we assessed
the RRV viruses for their ability to activate IRF-3, a step that is
independent of de novo host RNA and protein synthesis and therefore
not susceptible to shutoff mediated effects (Preston, Harman, and
Nicholl, 2001). IRF-3 is an essential transcription factor that is
Fig. 6. Characterization of virus-induced shutoff by the RRV A532V mutant. L929 cells were either mock infected (M) or infected at an MOI of 50 with RRV (R) or A532V (V). (A) At
various times post-infection (2, 5, 8, and 16 h), cells were labeled with 20 μCi/ml of 3H-Uridine (as previously described) for analysis of host RNA synthesis. (B) L929 cells were
labeled with 35S Met/Cys at the indicated times post-infection for 1 h to monitor host protein synthesis. Total cell lysates (duplicates) were analyzed by SDS-PAGE as described in
the Materials and methods. (C) The kinetics of cellular β-actin protein synthesis was evaluated by measuring the amount of radioactivity detected by densitometry in the β-actin
protein band in the infected cells and normalized to the mock infected cells at 24 hpi. (D) L929 cells were either mock infected or infected with RRV or A532V mutant viruses at an
MOI (50). Supernatants at 24 hpi were analyzed for IFN by bioassay as previously described. The limit of detection in this assay is 2 IU/ml and each bar represents the average of
triplicate samples. The p values were determined by ANOVA statistical analysis and error bars represent the standard error of the mean.
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pattern receptors to induce early transcription of IFN-β and IFN-α
genes. Activation is initiated upon IRF-3 phosphorylation resulting in
protein dimerization and nuclear translocation. Therefore, we
assessed whether the mutant RRV virus exhibited differential IRF-3
activation compared to the wild type RRV in L929 cells, which
exhibited high levels of type I IFN induction by the RRV A532Vmutant
(Fig. 4A). L929 cells were transfected with poly IC as a positive control
(Hato et al., 2007), which resulted in robust IRF-3 phosphorylation as
indicated by the shift in the IRF-3 protein band in comparison to the
mock treated cells (Fig. 7A). Additionally, phosphatase treatment ofcell lysates conﬁrmed that the upper band was indeed a phosphor-
ylated protein (data not shown). Analysis of the virally infected cells
demonstrated that the RRV A532V mutant virus-induced IRF-3
phosphorylation at 10 h post-infection; however, the wild type RRV
virus did not display IRF-3 phosphorylation until as late as 12 h post-
infection. Also, there was substantially more IRF-3 phosphorylation at
12 h post-infection in cells infected with the A532V mutant virus
(Fig. 7B), consistentwith our previousdata that the RRVA532Vmutant
induces more IFN than wild type RRV. Similar to the results with RRV,
the AR86 T538I mutant induced faster and more robust IRF-3
activation than thewild type virus inHEC-1B cells, humanendometrial
Fig. 7. The RRV A532Vmutant robustly induces IRF-3 phosphorylation compared to wild type virus. (A) L929 cells were either mock infected, infected with RRV and A532V viruses at
an MOI of 5, or transfected with 1ug of poly I:C with Lipofectamine 2000 (Invitrogen). Cells were lysed at the indicated hours in NP40 lysis buffers containing protease and
phosphatase inhibitors. 20 µg of total protein was analyzed by SDS-PAGE and probed with an anti-IRF-3 antibody (Santa Cruz, C-20) for phosphorylated murine IRF-3 (p-IRF-3). The
membranes were then re-probed with an anti-β-actin antibody (Sigma). (B) The phosphorylated IRF-3 bands in (A) were quantiﬁed using ImageQuant 5.0 and represented as fold
over mock. The data shown are representative of three independent experiments.
7C.C. Cruz et al. / Virology 399 (2010) 1–10carcinoma cells, that have been well characterized in IRF-3 activation
studies and do not respond to IFN treatment (Chen et al., 1981; Talon
et al., 2000) (data not shown). Altogether, these results suggest that
both the AR86 and RRV mutants affect IFN induction through a
mechanism that is independent of virus-induced host shutoff.
However, given that the RRV A532V mutant did exhibit delayed
shutoff kinetics in BHK cells, we cannot rule out a synergistic role for
shutoff dependent and independent effects in enhancing type I IFN
induction by the RRV A532V mutant.
Discussion
Type I interferon is an essential component of the host response to
viral infection, because it directly activates antiviral systems and
modulates antiviral activities of other components of the host innate
and adaptive immune systems. However, a number of viruses have
evolved mechanisms to antagonize or evade type I IFN induction.
These mechanisms range from nonspeciﬁc effects, such as rapid
shutoff of host cell macromolecular synthesis (Ahmed et al., 2003;
Gorchakov et al., 2005), masking viral RNA from host cell sensory
proteins (Cardenas et al., 2006; Mibayashi et al., 2007), to speciﬁc
inhibition of host cell dsRNA sensors or signaling molecules that link
these sensor molecules to transcription factors that regulate type I
interferon transcription (Andrejeva et al., 2004; Basler et al., 2003; Li
et al., 2005; Loo et al., 2006). Studies with Sindbis virus suggest that
host cell shutoff plays a major role in regulating viral type I interferon
induction (Gorchakov et al., 2005), though studies with Semliki Forest
virus (SFV) also indicate that alphaviruses can modulate type I IFN
responses independently of host shutoff (Breakwell et al., 2007). In
this report, we present evidence that an attenuating mutation at nsP1
position 538 (T538I) in the neurovirulent strain of Sindbis virus, AR86,
modulates type I interferon induction without affecting this virus's
ability to shut off host cell macromolecular synthesis. Additionally,
this determinant has been shown to play a key role in regulating viral
neurovirulence (Heise et al., 2000), and it is likely that the enhanced
type I IFN induction by the nsP1 538mutant virus in vivo (Fig. 1A) is at
least partially responsible for its attenuating effect on AR86.
Furthermore, the importance of this determinant in regulating typeI IFN induction by alphaviruses is underscored by our ﬁnding that an
analogous mutation in another alphavirus, Ross River Virus, exerts a
similar effect on type I IFN induction (Figs. 4 and 5).
Using a genetically related Sindbis virus, Gorchakov et al. (2005)
demonstrated that viruses with mutations resulting in defects in host
translation or transcription shutoff induced more type I interferon.
However, we found either no difference or a very mild defect in host
shutoff with the mutant Sindbis and RRV viruses, as well as
differences in the kinetics of virus-induced IRF-3 activation, which is
independent of host shutoff. This ﬁnding strongly suggests that these
viruses can affect type I IFN induction independently of effects on host
shutoff. It is also important to note that previous workwith an SFV nsP
mutant, which also demonstrated a role for the nonstructural proteins
in modulating type I IFN induction independently of host shutoff
effects, did not observe a differential effect on IRF-3 activation
(Breakwell et al., 2007), which raises the possibility that the
determinants in our AR86 and RRV mutants may affect interferon
induction through different mechanisms than those observed with
SFV. Furthermore, previous studies from our lab and others have
demonstrated a role for VEE to inhibit STAT-1 activation (Simmons
et al., 2009; Yin et al., 2009), a necessary step in the IFN signaling
pathway to amplify the type I IFN response indicating that these
viruses may employ additional mechanisms to antagonize this
pathway. However, our analysis in IFN αβ Receptor deﬁcient MEFS,
coupled with preliminary data that wild type RRV does not inhibit
STAT-1 activation, further suggests that our determinant is affecting
the initial IFN induction step.
The nsP1 virulence determinant described here might affect type I
IFN induction through several different mechanisms. First, the nsP1
mutant may induce more type I IFN by producing earlier and/or
increased quantities of a viral ligand, for efﬁcient recognition by the
host sensors. Previous studies examining very early times post-
infection demonstrated that the AR86 mutant virus initiated 26S RNA
synthesis more quickly than the wild type virus, though both viruses
exhibited equivalent levels of 26S RNA synthesis by 4–6 h post-
infection (Heise et al., 2003). Although, we did not observe this kinetic
difference in our L929 RNA labeling assays, this likely reﬂects the time
points analyzed in the current studies. Our earlier results raise the
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mutant virus might be linked to the difference in type I IFN
induction. Preliminary analysis indicates that the RRV mutant may
also produce more viral RNA than the wild type virus (data not
shown). In this model, the wild type virus could delay 26S promoter
induction until later times when virus-induced host shutoff
efﬁciently antagonizes type I interferon induction. The attenuating
mutation at nsP1, however, up-regulates 26S RNA synthesis prior to
the time of effective virus-induced shutoff (Heise et al., 2003). This
model suggests that the subgenomic RNA may be a potential target
for host cell sensors, however; this does not rule out a role for
multiple viral RNA species, such as the full length positive or
negative sense RNA, or dsRNA complexes to activate IFN induction.
Further investigations will be required to address the exact viral
ligand required as well as the pathway that is mediating this
response and whether this mechanism holds true for both viruses.
Second, the nsP1 mutant may induce more type I IFN by altering the
structure of one or more viral RNAs and thereby producing a
stronger ligand. Gitlin et al. (2006) have reported that RIG-I plays an
important role in responding to Sindbis virus infection, while PKR
has also been shown to contribute to type I IFN induction during
ﬂavivirus infection (Gilfoy and Mason, 2007). Both RIG-I and PKR
interact with 5′-triphosphates on uncapped RNAs (Hornung et al.,
2006; Nallagatla et al., 2007; Pichlmair et al., 2006), though both
proteins can also recognize other RNA ligands (Nallagatla and
Bevilacqua, 2008; Saito and Gale, 2008). Both nsP1 and nsP2
proteins are involved in capping viral RNAs and though the C-
terminus of nsP1 has not been implicated in capping activity, it is
possible that the determinant at nsP1 is altering the efﬁciency of
capping viral genomic or subgenomic RNAs (Ahola and Kaariainen,
1995; Ahola et al., 1997; Hornung et al., 2006; Mi et al., 1989;
Rikkonen et al., 1994; Vasiljeva et al., 2000). In this model, the nsP1
mutants are providing the host sensor, RIG-I, with viral ligands that
contain free 5′-triphosphates that lead to stronger IFN-β induction.
Finally, though there is no direct evidence to suggest that the wild
type and T538I mutant Sindbis AR86 viruses or RRV and the A532V
RRV mutant differ in their ability to actively suppress type I IFN
induction, it is possible that the mutation is modulating type I IFN
induction through different mechanisms in the context of each virus.
Regardless of the ultimate mechanism responsible for the differen-
tial type I IFN induction phenotype, these results further support the
idea that determinants in the viral nonstructural region of
alphaviruses play a major role in regulating type I IFN induction,
with a concomitant impact on viral virulence.
In summary, we have demonstrated that wild type AR86 virus was
a poor inducer of type I interferon, while the mutant T538I virus
containing an attenuating Ile codon at nsP1 position 538 induced a
robust type I interferon response in vitro and in vivo. An analogous
determinant exhibited a similar effect in another, distantly related
alphavirus (RRV), suggesting that this determinant plays an impor-
tant role in regulating type I IFN induction by multiple alphaviruses.
The altered interferon induction was independent of virus-induced
host translation or transcription shutoff, suggesting that the deter-
minant within the nsP1/nsP2 cleavage site acts through a more
speciﬁc mechanism to modulate the host type I interferon response.
Materials and methods
Viruses and cell culture
The AR86 molecular clones pS300 (wild type nsP1 538 Thr) and
pS340 (mutant nsP1 538 Ile) were described previously (Heise et al.,
2000). The wild type Ross River Virus molecular clone, pRR64 (Kuhn
et al., 1991), was generously provided by Dr. Richard Kuhn (Purdue
University). The Ross River Virus mutant, pRR64-A532V, was
generated by introducing a single nucleotide change (thymine toguanine) at nucleotide position 1670, by PCRmutagenesis resulting in
a single codon change from an Alanine (wild type) to Valine (A532V)
at nsP1 position 532.
Viral stocks were generated by in vitro transcription as previously
described (Heise et al., 2003; Morrison et al., 2006). Brieﬂy, cDNA
plasmids were linearized and used as templates for full length RNA
transcripts generated by SP6-speciﬁc mMessage mMachine in vitro
transcription kits (Ambion). Transcripts were electroporated into
BHK-21 cells using a Bio-Rad electroporator. Supernatants were
harvested 24 h later, centrifuged for 20 min at 3,000 RPM, and frozen
in 0.5 ml aliquots. Alternatively, electroporated supernatants were
pelleted through a 20% (w/v) sucrose/phosphate-buffered saline
(PBS) cushion at 72,000×g by ultracentrifugation (4 h) to concentrate
viral stocks. The pelleted viruses were resuspended in PBS and 0.1 ml
aliquots were frozen at −80 °C. Viral titers were determined by
standard plaque assays on BHK-21 cells.
BHK-21 cells were maintained in alpha minimum essential
medium (Gibco) supplemented with 10% bovine calf serum
(BioWhittaker), 10% tryptose phosphate broth, and 0.29 mg/ml of
L-glutamine. L929 mouse ﬁbroblast cells were maintained in alpha
minimum essential medium (Gibco) supplemented with 10% bovine
calf serum, 10% tryptose phosphate broth, and 0.29 mg/ml of L-
glutamine. Neuro2A mouse neuroblastoma cells (N2A) were grown
in MEM containing nonessential amino acids and 10% fetal bovine
serum (HyClone). HEC-1B cells (ATCC) were grown in MEM
containing 10% fetal bovine serum, 0.29 mg of L-glutamine per ml,
and penicillin/streptomycin. Primary Mouse Embryonic Fibroblast
(MEFS) cells were generated from 13–15 day old Sv/129 wild type or
IFN αβ receptor deﬁcient (IFNR−/−) embryos and maintained in
DMEM/F12 media containing 10% Fetal Bovine Serum, 10% tryptose
phosphate broth, 0.29 mg/ml of L-glutamine, and 50 µg/ml of
gentamicin (Gibco).
Animal studies
Speciﬁc pathogen-free six-week old female CD-1 mice were
obtained from Charles River Breeding Laboratories (Raleigh, NC),
while C57Bl/6J mice were bred in house. Animal housing and care
were in accordance with all University of North Carolina at Chapel Hill
Institutional Animal Care and Use Committee guidelines. In all studies,
six- to eight-week-old mice (groups of 3 to 6 animals/study) were
anesthetized with Ketamine supplemented with Xylazine (Barber
Med.) prior to intracranial (i.c.) inoculation with a standard dose of
103 PFU of virus in diluent [phosphate-buffered saline (PBS, pH 7.4)],
supplemented with 1% donor calf serum (DCS, Gibco). Mock infected
mice received diluent alone. At the indicated timepoints, mice were
bled from the tail vein and sera were frozen at−80 °C until analyzed
for type I interferon by bioassay (see below).
Type I IFN bioassays
Total amounts of type I IFN were measured by using an interferon
bioassay as previously described (Shabman et al., 2007). Brieﬂy, L929
cells were seeded in 96 well plates. Samples, including the standards,
were acidiﬁed to a pH≤2.0 for 24 h, then neutralized to pH of 7.4, UV
treated for 10 min to inactivate residual virus, and added to cells in a
titration of serial two-fold dilutions. After overnight incubation, 50 µl
of a 4×106 PFU/ml stock of encephalomyocarditis virus (EMCV) was
added to each well. Twenty-four hours post-infection, cell viability
was determined using 3-(4, 5-Dimethylthiazol-2-yl)-2,5-diphenylte-
trazolium bromide (MTT, Sigma) assay, and the absorbance was read
on a microplate reader at 570 nm. The IFN in each sample was
compared to an IFN standard (from Chemicon or R and D Systems
that have been normalized to the National Institutes of Health
reference IFN) present in each plate and converted to international
units (IU/ml).
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L929 cells were seeded in 6-well dishes and either mock infected
or infected with RRV wild type and A532V RRV mutant viruses at an
MOI of 5. At the indicated time points, total RNAwas isolated using the
Trizol (Invitrogen) and the PureLink RNA Mini Kit protocol (Invitro-
gen). Total RNA was reverse transcribed using random primers and
SuperScript III Reverse Transcriptase Kit (Invitrogen). cDNAs were
then probed for IFN-beta and 18S rRNA message using TaqMan real-
time PCR with primer probe sets (Applied Biosystems) and analyzed
on the Prism 7000 machine (Applied Biosystems).
Analysis of protein synthesis
L929, BHK-21, or Neuro2A cells were either mock infected or
infected with the Sindbis AR86 or RRV viruses at an MOI of 50 and 10
(BHK and N2A). At various times post-infection, the media was
removed and cells were starved with Minimum Essential Eagle
Medium with Earle's salts lacking methionine and Cysteine (MP
biomedicals) for 1 h at 37 °C. The starvation media was then replaced
with media supplemented with 33 μCi of 35S-methionine and 35S-
cysteine (Amersham Pro-mix) and incubated at 37 °C for 1 h.
Following each labeling period, cells were lysed in NP-40 Lysis buffer
containing protease inhibitors (Roche). Equal cell lysates were
analyzed on a 10% sodium dodecyl sulphate polyacrylamide gel
(SDS-PAGE). Gels were ﬁxed in buffer containing 10% acetic acid and
40% methanol. The gels were then dried, exposed to a phosphoima-
ging screen, and scanned using a Storm Phosphoimager (GE
Healthcare). β-actin bands were quantiﬁed using ImageQuant
software (GE Healthcare), and samples are represented as comparison
to mock infected cells.
Analysis of host RNA synthesis
L929, BHK, or Neuro2A cells were either mock infected or infected
with the Sindbis AR86 or the RRV viruses at an MOI of 50 and 10 (BHK
and N2A). After 1 h of incubation, 2 ml of media was added back to
cells. At various times post-infection (2, 5, 8, and 16 hpi), the media
were replacedwithmedia supplemented with 20 µCi/ml [3H]-uridine
(in the presence or absence of actinomycin D (1 µg/ml)). The cells
were labeled for a total of 3 h, then washed with 1× PBS and lysed in
Trizol (Invitrogen). RNA was extracted and equal volumes were
denatured in glyoxal and dimethyl sulfoxide (DMSO) for 1 h at 50 °C.
The RNA was analyzed on a 0.8% agarose NaPO4 gel. The agarose gel
was washed twice in methanol followed by overnight incubation in
2.5% 2, 5-diphenyloxazole (PPO) in methanol. The gel was washed
three times in water to precipitate the PPO, dried, and exposed to ﬁlm.
SDS-PAGE and Western blot analysis
Protein extracts were resolved on 10% SDS-PAGE followed by
transfer to a PVDF membrane. Anti-IRF-3 C-20 antibody (Santa Cruz)
was used for detection of phosphorylated IRF-3 in L929 cells. For re-
probing of the membranes, anti-β-actin (Sigma) antibodies were
used.Membraneswerewashed and incubated in the appropriate anti-
rabbit and anti-goat secondary antibodies.
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